安纳普蒂斯生物 ANAB
$46.45 +$0.87 (+1.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $45.80 -1.40%
开盘$45.85
昨收$45.58
当日区间$45.01 – $46.63
成交量287.8K
市值$1.39B
市盈率（TTM）8.3
股息率–
基本面
最新报告季度：Q1, ended Mar 2026
营收$25.56M-8.0% YoY
营业利润-$34.64M-25.8% YoY
净利润-$52.88M-34.5% YoY
摊薄每股收益-$1.84-43.8% YoY
自由现金流-$25.94M-141.6% YoY
经营现金流-$25.92M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率17.6%
净利率-11.5%
净资产收益率-114.6%
资产收益率-7.1%
投入资本回报率41.6%
流动比率7.58
负债/资产比率96.1%
现金及投资$286.46M
总负债$11.49M
净现金（净负债）$274.96M
自由现金流/营收1.9%
利润表
| 项目 | 2026 ANNUAL | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $53.04M | $25.56M | $234.60M | $108.25M | $76.32M |
| 营业总收入 | $53.04M | $25.56M | $234.60M | $108.25M | $76.32M |
| 营业费用 | $20.72M | $60.19M | $7.70M | -$137.66M | $41.62M |
| 销售及管理费用 | $23.39M | $26.20M | $11.35M | -$23.60M | $10.21M |
| -管理费用 | $23.39M | $26.20M | $11.35M | -$23.60M | $10.21M |
| 研发费用 | -$2.67M | $33.99M | -$3.64M | -$114.06M | $31.41M |
| 营业利润 | $32.32M | -$34.64M | $226.90M | $245.91M | $34.70M |
| 非经营性利息净收入（支出） | -$37.94M | -$18.21M | -$70.08M | -$20.89M | -$19.59M |
| 非经营性利息收入 | $3.25M | $2.65M | $9.81M | -$1.18M | $2.92M |
| 非经营性利息支出 | $41.19M | $20.86M | $79.89M | $19.71M | $22.52M |
| 其他收入（支出） | $525,000.00 | -$1,000.00 | $5.45M | $20,000.00 | – |
| 其他非经营性收入（支出） | $525,000.00 | -$1,000.00 | $5.45M | $20,000.00 | – |
| 税前利润 | -$5.09M | -$52.84M | $162.28M | $225.04M | $15.11M |
| 税费 | -$181.45M | $40,000.00 | $772,000.00 | $689,000.00 | $0.00 |
| 净利润 | $131.00M | -$52.88M | -$13.23M | $49.61M | $15.11M |
| 持续经营利润 | $176.36M | -$52.88M | $161.50M | $224.35M | $15.11M |
| 终止经营净利润 | -$45.36M | – | -$174.74M | – | – |
| 归属母公司净利润 | $131.00M | -$52.88M | -$13.23M | $49.61M | $15.11M |
| 归属普通股股东净利润 | $131.00M | -$52.88M | -$13.23M | $49.61M | $15.11M |
| 基本每股收益 | $4.52 | -$1.84 | -$0.46 | $1.79 | $0.54 |
| 摊薄每股收益 | $3.50 | -$1.84 | -$0.46 | $1.58 | $0.52 |
资产负债表
| 项目 | 2026 ANNUAL | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $316.98M | $329.68M | $364.40M | $364.40M | $353.10M |
| 流动资产合计 | $198.43M | $316.11M | $350.25M | $350.25M | $330.65M |
| 现金及现金等价物与短期投资 | $164.14M | $286.46M | $211.64M | $211.64M | $248.96M |
| -现金及现金等价物 | $133.83M | $248.47M | $138.20M | $138.20M | $109.83M |
| -短期投资 | $30.32M | $37.99M | $73.44M | $73.44M | $139.12M |
| 应收款 | $25.63M | $25.75M | $33.85M | $33.85M | $75.69M |
| -应收账款 | $25.63M | $25.75M | $33.85M | $33.85M | $75.69M |
| 其他流动资产 | $8.65M | $3.91M | – | – | $6.01M |
| 非流动资产合计 | $118.56M | $13.58M | $14.15M | $14.15M | $22.45M |
| 固定资产净值 | $11.66M | $13.32M | $12.63M | $12.63M | $14.49M |
| -固定资产原值 | $11.76M | $20.59M | $12.72M | $12.72M | $21.50M |
| -累计折旧 | -$101,000.00 | -$7.27M | -$92,000.00 | -$92,000.00 | -$7.01M |
| 投资及预付款 | $0.00 | – | $0.00 | $0.00 | $7.70M |
| 一年以上递延资产 | $106.64M | – | $0.00 | $0.00 | – |
| 其他非流动资产 | $256,000.00 | $256,000.00 | $1.52M | $1.52M | $256,000.00 |
| 负债合计 | $306.40M | $316.94M | $327.19M | $327.19M | $382.51M |
| 流动负债合计 | $35.35M | $41.70M | $38.63M | $38.63M | $38.10M |
| 应付款 | $4.39M | $7.52M | $3.87M | $3.87M | $2.89M |
| -应付账款 | $4.39M | $7.52M | $3.87M | $3.87M | $2.89M |
| 一年内应计费用 | $22.93M | $26.53M | $21.58M | $21.58M | $24.16M |
| 短期债务及融资租赁负债 | $2.16M | $2.12M | $2.08M | $2.08M | $2.04M |
| -一年内到期融资租赁负债 | $2.16M | $2.12M | $2.08M | $2.08M | $2.04M |
| 非流动负债合计 | $271.05M | $275.24M | $288.56M | $288.56M | $344.41M |
| 长期应付账款及其他应付款 | $3.62M | – | $0.00 | $0.00 | – |
| 长期债务及融资租赁负债 | $10.93M | $11.49M | $12.03M | $12.03M | $12.57M |
| -长期融资租赁负债 | $10.93M | $11.49M | $12.03M | $12.03M | $12.57M |
| 其他非流动负债 | $256.49M | $263.74M | $276.53M | $276.53M | $331.84M |
| 股东权益合计 | $10.59M | $12.75M | $37.21M | $37.21M | -$29.42M |
| 股东权益 | $10.59M | $12.75M | $37.21M | $37.21M | -$29.42M |
| 股本 | $30,000.00 | $29,000.00 | $28,000.00 | $28,000.00 | $28,000.00 |
| -普通股 | $30,000.00 | $29,000.00 | $28,000.00 | $28,000.00 | $28,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $652.27M | $838.31M | $809.77M | $809.77M | $792.68M |
| 留存收益 | -$641.56M | -$825.44M | -$772.56M | -$772.56M | -$822.17M |
| 不影响留存收益的损益 | -$151,000.00 | -$146,000.00 | -$24,000.00 | -$24,000.00 | $47,000.00 |
现金流量表
| 项目 | 2026 ANNUAL | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$52.56M | -$25.92M | $19.70M | $98.00M | -$27.36M |
| 持续经营经营活动现金流净额 | -$1.40M | -$25.92M | $161.79M | $240.09M | -$27.36M |
| 持续经营净利润 | $176.36M | -$52.88M | $161.50M | $224.35M | $15.11M |
| 持续经营损益 | $41.19M | – | $79.89M | – | – |
| 折旧、折耗与摊销 | $968,000.00 | $610,000.00 | $1.88M | $67,000.00 | $610,000.00 |
| 递延税款 | -$183.70M | – | $0.00 | – | – |
| 营运资金变动 | -$44.57M | -$8.71M | -$80.53M | $20.10M | -$73.62M |
| -应收款变动 | $4.97M | $8.10M | $6.92M | $41.84M | -$54.27M |
| -预付资产变动 | -$3.67M | $1.50M | $1.81M | $1.17M | -$303,000.00 |
| -应付账款及应计费用变动 | -$44.85M | -$17.82M | -$87.33M | -$22.42M | -$18.56M |
| -其他流动负债变动 | -$1.02M | -$499,000.00 | -$1.93M | -$494,000.00 | -$490,000.00 |
| 终止经营经营活动现金流 | -$51.16M | – | -$142.09M | – | – |
| 投资活动现金流净额 | $42.55M | $34.98M | $228.03M | $73.50M | $103.28M |
| 持续经营投资活动现金流净额 | $42.55M | $34.98M | $228.12M | $73.59M | $103.28M |
| 投资购置及出售净额 | $42.55M | $35.00M | $228.12M | $73.50M | $103.29M |
| 筹资活动现金流 | -$94.36M | $1.21M | -$132.61M | -$43.13M | -$10.39M |
| 持续经营筹资活动现金流净额 | $5.64M | $1.21M | -$132.61M | -$43.13M | -$10.39M |
| 普通股发行净额 | $25.37M | $14.02M | -$54.37M | $8.83M | -$9.38M |
| 股票期权行使所得 | $0.00 | $0.00 | -$1.45M | $0.00 | $0.00 |
| 其他筹资费用净额 | -$19.73M | -$12.81M | -$76.80M | -$51.96M | -$1.01M |
| 终止经营筹资活动现金流 | -$100.00M | – | $0.00 | – | – |
| 期末现金余额 | $133.83M | $248.47M | $138.20M | $138.20M | $109.83M |
| 现金净变动 | -$104.37M | $10.27M | $115.12M | $128.36M | $65.54M |
| 期初现金余额 | $238.20M | $238.20M | $23.08M | $109.83M | $44.30M |
| 自由现金流 | -$52.56M | -$25.94M | $19.70M | $98.08M | -$27.37M |
| 其他非现金项目 | – | $20.86M | – | – | $22.52M |
| 固定资产购置及出售净额 | – | -$17,000.00 | – | – | -$12,000.00 |
暂无评论——快来第一个聊聊 ANAB。